Kurarinol, tyrosinase inhibitor isolated from the root of Sophora flavescens
It is well known that flavanones, sophoraflavanone G 1, kurarinone 2, and kurarinol 3, from the root of Sophora flavescens, have extremely strong tyrosinase inhibitory activity. This study delineates the principal pharmacological features of kurarinol 3 that lead to inhibition of the oxidation of l-...
Saved in:
Published in | Phytomedicine (Stuttgart) Vol. 15; no. 8; pp. 612 - 618 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Elsevier GmbH
01.08.2008
Urban & Fischer Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | It is well known that flavanones, sophoraflavanone G
1, kurarinone
2, and kurarinol
3, from the root of
Sophora flavescens, have extremely strong tyrosinase inhibitory activity. This study delineates the principal pharmacological features of kurarinol
3 that lead to inhibition of the oxidation of
l-tyrosine to melanin by mushroom tyrosinase (IC
50 of 100
nM). The inhibition kinetics analyses unveil that compounds
1 and
2 are noncompetitive inhibitors. However similar analysis shows kurarinol
3 to be a competitive inhibitor. Compounds
1 and
2 exhibited potent antibacterial activity with 10
μg/disk against Gram-positive bacteria, whereas kurarinol
3 did not ostend any antibacterial activity. Interestingly, kurarinol
3 inhibits production of melanin in
S. bikiniensis without affecting the growth of microorganism. It is thus distinctly different from the other tyrosinase inhibitors
1 and
2. In addition, kurarinol
3 manifests relatively low cytotoxic activity (EC
50>30
μM) compared to
1 and
2. To account for these observations, we conducted molecular modeling studies. These suggested that the lavandulyl group within 3 is instrumental in the interaction with the enzyme. More specifically, the terminal hydroxy function within the lavandulyl group is most important for optimal binding. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0944-7113 1618-095X |
DOI: | 10.1016/j.phymed.2007.09.022 |